Duke aspires to create a community built on collaboration, innovation, creativity, and belonging. Our collective success depends on the robust exchange of ideas an exchange that is best when the rich diversity of our perspectives, backgrounds, and experiences flourishes. To achieve this exchange, it is essential that all members of the community feel secure and welcome, that the contributions of all individuals are respected, and that all voices are heard. All members of our community have a responsibility to uphold these values.

Government to include Oseltamivir and Zanamivir in Schedule H1 after the consultation with the Drugs Technical Advisory Board.

The new policy, on environmental sustainability within pharmacy, expands on a 2016 FIP statement on the importance of reducing the environmental impact of pharmaceuticals and related activities. It makes clear that environmental sustainability includes both mitigation measures, such as reducing pharmaceutical pollution and greenhouse gas emissions, as well as adaptation measures to climate change.

NIAB, an autonomous institute under the aegis of the Department of Biotechnology, Ministry of Science & Technology, Government of India, is aimed to harness novel and emerging biotechnologies and create knowledge in the cutting edge areas for improving animal health and productivity. The Institute’s research focus is on animal genetics and genomics, transgenesis, stem cell & its applications, reproductive biotechnology, infectious diseases, nanotechnology, bioinformatics and Nutrigenomics.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including India.  The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South America and India.

Sun Pharma is the fourth largest generic pharmaceutical company in the world It is also Indias largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high quality medicines trusted by customers and patients in over ISO countries and has multiple manufacturing facilities and R&D centers. Our leadership is approachable, recognizes people's passions for growth, gives them a voice and empowers them to make a positive change.

Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~1.9 billion usd in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices.

Vacancy for M.Pharm, M.Tech, MSc as Project Associate at NIAB
Post Graduate Degree in life sciences OR Graduate / Post Graduate degree in professional course. M.V.Sc. / M.Tech./ MSc./ M.Pharm Degree in Biotechnology Biochemistry / Microbiology / Immunology with first division.

AIIMS Nagpur is an apex healthcare institute, established by the Ministry of Health and Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojna (PMSSY) with the aim of correcting regional imbalances in quality tertiary level healthcare in the country and attaining self-sufficiency in graduate and postgraduate medical education and training.

Post : Pharmacist

District Health Society, (Health Branch) District Health Society under Gujarat Urban Health Project (GUHP) Zilla Panchayat Mahisagar Lunawada among the sanctioned posts in the year 2023-24 the following vacancies for 11 months contract based on monthly fixed salary recruitment of candidates based on merit list Certificates to be done on and occurs.

Post : Pharmacist

IICB Institute was established in 1935 as the first non official centre in India for biomedical research and was included within the aegis of CSIR in 1956. IICB today is engaged in research on diseases of national importance and biological problems of global interest, employing sophisticated state-of-the-art technology in keeping with the rapid and unprecedented momentum that life science research has gained globally over the last 50 years.

All India Institute of Medical Sciences (AIIMS), Kalyani, an Institute of National Importance is one of the new upcoming AIIMS and apex healthcare Institute under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) has been established by the Ministry of Health and Family Welfare, Govt. of India, with the aim of correcting regional imbalance in quality tertiary level healthcare in the country, and attaining self-sufficiency in graduate, postgraduate and higher medical education and training.

NIAB, an autonomous institute under the aegis of the Department of Biotechnology, Ministry of Science & Technology, Government of India, is aimed to harness novel and emerging biotechnologies and create knowledge in the cutting edge areas for improving animal health and productivity. The Institute’s research focus is on animal health and production with an special emphasis on Reproductive Biotechnology, infectious biology, Genomics, transgenesis, stem cell biology, nutrition, nanobiology and bioinformatics.

Maithri Drugs is one of Indias fast-growing pharmaceutical companies. Maithris strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research and development and aggressive growth strategies. Our 39 US DMFs and 14 CEPs in a short span attest to our R&D excellence.

Post : Junior Executive's / Executive's - QC (Method Validation) Department

Aculife Healthcare Pvt. Ltd Company is a part of Nirma Group & it is one of world's largest Infusion & Injectable Company, having a State-of-the art manufacturing facility spread over 550 acres of land located near Ahmedabad, Gujarat. Aculife healthcare has global operation in more than 100 countries and it has subsidiaries in Brazil, Mexico & Vietnam. The manufacturing facility has 2 plants with FFS technology, 1 Glass injectable plant and a one dedicated R&D center equipped with advance technology and unmatched research team.

How are environmental changes, loss of biodiversity, and the spread of pathogens connected? The answer is a puzzle. Researchers from Charité – Universitätsmedizin Berlin have now described one piece of that puzzle in the journal eLife,* showing that the destruction of tropical rainforests harms the diversity of mosquito species. At the same time, more resilient species of mosquitoes become more prevalent – which also means the viruses they carry are more abundant. If there are many individuals of a given species, those viruses can spread quickly.

Ratnatris Pharmaceuticals Pvt. Ltd., a WHO GMP certified "State of Art" manufacturing facility, that manufactures General Therapeutics and Antibiotic Drugs, Tablets, Capsules, Oral Liquid, Dry Powder, and SVP. Ratnatris Pharmaceuticals is having footprints in various countries in Africa, South East Asia, Latin America, Middle East, and CIS Zone.

Legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Looking for competent young professionals to be an integral part of our team for API & Formulations (OSD) manufacturing site at Panelav and Jarod near Vadodara (Gujarat).

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.